Stock listing
Cervomed Inc.
Selected listing: DP8 · TRADEGATE · EUR · DE
Cervomed Inc. (Tradegate:DP8), Commercial Services. Latest release Sep 28, 2026: CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet…
- Ticker
- Tradegate:DP8
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- Tradegate
- Currency
- EUR
About Cervomed Inc.
Cervomed Inc. (CRVO) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Cervomed Inc.
CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit
September 28, 2026
CervoMed to Participate in the 5th Annual ROTH Healthcare Opportunities Conference
September 22, 2026
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026
September 10, 2026
CervoMed to Participate in September Investor Conferences
September 8, 2026
CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
August 10, 2026
Research Cervomed Inc.
Alternate listings
CRVO:NASDAQ
US · USD
Alternate listing for Cervomed Inc.; the primary context on this page is DP8:TRADEGATE.
A3ES01:LSX
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is DP8:TRADEGATE.
A3ES01:LS
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is DP8:TRADEGATE.
CRVO:BOATS
US · USD
Alternate listing for Cervomed Inc.; the primary context on this page is DP8:TRADEGATE.
DP8:FWB
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is DP8:TRADEGATE.
DP8:SWB
DE · EUR
Alternate listing for Cervomed Inc.; the primary context on this page is DP8:TRADEGATE.